Influence of serum cholesterol and cholesterol subfractions on restenosis following successful coronary intervention.
Violaris
A G
AG
Cardiology Unit, St Mary's Hospital, London, UK. a.violaris@ic.ac.uk
Ismail
T F
TF
El-Gendi
H
H
Foale
R A
RA
D015906:Angioplasty, Balloon, Coronary; D000924:Anticholesteremic Agents / Q000008:administration & dosage; D008076:Cholesterol, HDL / Q000097:blood* / Q000378:metabolism; D008078:Cholesterol, LDL / Q000097:blood* / Q000378:metabolism; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000150:complications* / Q000628:therapy*; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control*; D008297:Male; D011379:Prognosis; D018570:Risk Assessment; D055502:Secondary Prevention; D016896:Treatment Outcome
D000924:Anticholesteremic Agents; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL